Masaoki Ito

10PUBLICATIONS
20CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Liquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Sep 26, 2026
Circulating Tumor DNA-Based Molecular Residual Disease in Early-Stage Non-Small-Cell Lung Cancer: Biology, Assays, and the Path Toward MRD-Guided Care.

|Sep 26, 2026
A Computational Histology Artificial Intelligence Prognostic Biomarker in Non-Small Cell Lung Cancer Using the Cancer Genome Atlas.

|Dec 30, 2025
Refining Surgical Standards: The Role of Robotic-Assisted Segmentectomy in Early-Stage Non-Small-Cell Lung Cancer.

Masaya Nishino, Hideki Ujiie, Masaoki Ito

|May 11, 2025
Dual inhibition of GTP-bound KRAS and mTOR in lung adenocarcinoma and squamous cell carcinoma harboring KRAS G12C.

Masaoki Ito, Yoshihiro Miyata, Shoko Hirano

|Apr 17, 2023
FOXA2 Cooperates with Mutant KRAS to Drive Invasive Mucinous Adenocarcinoma of the Lung.

Koichi Tomoshige, William D Stuart, Iris M Fink-Baldauf

|Oct 13, 2021
Pathological high malignant grade is higher risk of recurrence in pN0M0 invasive lung adenocarcinoma, even with small invasive size.

Masaoki Ito, Yoshihiro Miyata, Kei Kushitani

Pageof 2

Frequent Collaborators

4 joint publications

Yasuhiro Tsutani

2 joint publications

Hideki Ujiie

1 joint publications

Koichi Tomoshige

1 joint publications

William D Stuart